Survival in non-Hodgkin's lymphoma by histology and family history

被引:10
作者
Ji, Jianguang [1 ,3 ]
Forsti, Asta [1 ,2 ,3 ]
Sundquist, Jan [1 ,3 ]
Lenner, Per [4 ]
Hemminki, Kari [1 ,2 ,3 ]
机构
[1] Lund Univ, Ctr Primary Hlth Care Res, CRC, S-20502 Malmo, Sweden
[2] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany
[3] Karolinska Inst, Ctr Family & Community Med, Huddinge, Sweden
[4] Norrlands Univ Hosp, Dept Oncol, Umea, Sweden
关键词
Non-Hodgkin's lymphoma; Family history; Histology; Survival; Hazard ratio; CELL LYMPHOMA; WALDENSTROMS MACROGLOBULINEMIA; FOLLICULAR LYMPHOMA; CANCER DATABASE; PROSTATE-CANCER; BREAST-CANCER; PROGNOSIS; SUBTYPE; GRADE-3; DISEASE;
D O I
10.1007/s00432-009-0618-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although survival has been studied for various subtypes of non-Hodgkin's lymphoma (NHL), there have been few comprehensive studies to quantify the prognosis, including all specific histologies. The effect of family history on survival in NHL has not been examined. We used the Swedish Family-Cancer Database to estimate hazard ratios in NHL by histology and family history. Using diffuse centroblastic lymphoma as reference (HR 1.0), patients with Waldenstrom's macroglobulinemia and hairy-cell leukemia had the best survival. Survival advantage was also noted among patients with lymphoplasmacytic lymphoma and different kinds of follicular lymphomas. For T-cell lymphoma, mycosis fungoides showed a favorable prognosis. As for survival by family history, a total of 98 familial cases were noted in our Database with a similar prognosis compared to sporadic cases in both parental and offspring generations. A non-significant familial concordance of either good or poor survival was noted among family members when probands' prognosis was stratified by survival time. Our results provide quantitative prognosis data for patients with NHL according to specific histologies. Patients with a familial NHL had a similar prognosis compared to patients with sporadic disease. The data suggest familial concordance in either good or poor survival among family members.
引用
收藏
页码:1711 / 1716
页数:6
相关论文
共 33 条
[1]   Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database [J].
Altieri, A ;
Bermejo, JL ;
Hemminki, K .
BLOOD, 2005, 106 (02) :668-672
[2]   Natural history of follicular grade 3 non-Hodgkin's lymphoma [J].
Bierman, Philip J. .
CURRENT OPINION IN ONCOLOGY, 2007, 19 (05) :433-437
[3]  
Brugières L, 1998, BLOOD, V92, P3591
[4]  
Campo E, 1999, SEMIN HEMATOL, V36, P115
[5]   The influence of familial and hereditary factors on the prognosis of breast cancer [J].
Chappuis, PO ;
Rosenblatt, J ;
Foulkes, WD .
ANNALS OF ONCOLOGY, 1999, 10 (10) :1163-1170
[6]  
*CTR EP, 2002, CANC INC SWED 2000 N
[7]   Waldenstrom's macroglobulinemia: Clinical features, complications, and management [J].
Dimopoulos, MA ;
Panayiotidis, P ;
Moulopoulos, LA ;
Sfikakis, P ;
Dalakas, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) :214-226
[8]  
Gatter K., 2002, DIAGNOSIS LYMPHOPROL
[9]  
Glass AG, 1997, CANCER, V80, P2311
[10]   Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples [J].
Goldin, LR ;
Landgren, O ;
McMaster, ML ;
Gridley, G ;
Hemminki, K ;
Li, XJ ;
Mellemkjaer, L ;
Olsen, JH ;
Linet, MS .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (10) :2402-2406